دورية أكاديمية
The analysis of the state of pharmaceutical provision of patients with hepatitis B and C according to public procurement of medicines ; Аналіз стану фармацевтичного забезпечення хворих на гепатит В та С за даними публічних закупівель лікарських засобів
| العنوان: | The analysis of the state of pharmaceutical provision of patients with hepatitis B and C according to public procurement of medicines ; Аналіз стану фармацевтичного забезпечення хворих на гепатит В та С за даними публічних закупівель лікарських засобів |
|---|---|
| المؤلفون: | Nozdrina, A. A., Volkova , A. V. |
| المصدر: | Социальная фармация в здравоохранении; Том 9 № 3 (2023); 3-16 ; Соціальна фармація в охороні здоров’я; Том 9 № 3 (2023); 3-16 ; Social Pharmacy in Health Care; Vol. 9 No. 3 (2023); 3-16 ; 2518-1564 ; 2413-6085 |
| بيانات النشر: | National University of Pharmacy |
| سنة النشر: | 2023 |
| المجموعة: | Social Pharmacy in Health Care (E-Journal) / Соціальна фармація в охороні здоров’я |
| مصطلحات موضوعية: | вірусні гепатити, фармацевтичне забезпечення, публічні закупівлі, противірусні препарати прямої дії, viral hepatitis, pharmaceutical supply, public procurement, direct-acting antiviral drugs |
| الوصف: | Aim. To analyze the state of pharmaceutical provision of patients with hepatitis B (HB) and C (HC) according to public procurement of medicines. Materials and methods. The materials of the study were data from the Prozorro Public Procurement System, the Public Health Center of the Ministry of Health of Ukraine, the State Register of Medicines of Ukraine, the Unified Clinical Protocols for Primary, Secondary (Specialized), Tertiary (Highly Specialized) Medical Care “Viral Hepatitis C in Adults” and “Viral Hepatitis B in Adults”, and the Clinical Guideline “Viral Hepatitis B”». The study used methods of content analysis, comparative analysis and logical generalization of the results using the graphical method, as well as mathematical and statistical methods of analysis. Results. It was determined that during the period of 2017-2021, the maximum expenditures for the procurement of direct-acting antiviral drugs (DAAs) was recorded in 2017 and amounted to UAH 48.4million. The amount of procurement in 2018 was 89% less compared to the previous year. In 2019, the maximum rate (%) of growth in the cost of purchasing medicines for the treatment of HS compared to the previous period was 401%. In 2020-2021, there was a gradual decrease to the minimum amount of UAH 2.4million in 2021. According to the results of the analysis of procurement of medicines for the treatment of HS in physical terms after a significant decrease in 2018, in 2019 and 2020, there was a considerable increase and the purchase of the maximum number of packages in 2020 (12 thousand); in 2021, the minimum number of medicines (1050 units) was purchased for the entire period of analysis. It was determined that the structure of public procurement in 2017 and 2018 was dominated by original medicines of the groups J05AP08 Sofosbuvir and J05AP51 Sofosbuvir and Ledipasvir. In 2017, their share in the total volume of purchases in monetary terms amounted to 96.9%, and in 2018 – 63.9% of the total amount. However, starting from 2019, procurement of generic drugs ... |
| نوع الوثيقة: | article in journal/newspaper |
| وصف الملف: | application/pdf |
| اللغة: | Ukrainian |
| العلاقة: | http://sphhcj.nuph.edu.ua/article/view/291249/284781Test; http://sphhcj.nuph.edu.ua/article/view/291249Test |
| DOI: | 10.24959/sphhcj.23.298 |
| الإتاحة: | https://doi.org/10.24959/sphhcj.23.298Test http://sphhcj.nuph.edu.ua/article/view/291249Test |
| حقوق: | Copyright (c) 2023 National University of Pharmacy ; http://creativecommons.org/licenses/by/4.0Test |
| رقم الانضمام: | edsbas.6D40C1C1 |
| قاعدة البيانات: | BASE |
| DOI: | 10.24959/sphhcj.23.298 |
|---|